Graviti Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
- Paid Up Capital ₹ 49.00 Cr
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 363.25 Cr
- Satisfied Charges ₹ 160.00 Cr
- Revenue Growth 29.02%
- Profit Growth -110.34%
- Ebitda 2981.05%
- Net Worth -1.01%
- Total Assets 12.63%
About Graviti Pharmaceuticals
Graviti Pharmaceuticals Private Limited (GPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 27 December 2012 and has a history of 12 years and four months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Abhayam Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 49.00 Cr.
The company currently has active open charges totaling ₹363.25 Cr. The company has closed loans amounting to ₹160.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Graviti Pharmaceuticals Private Limited India is Murali Vasudeva as COMPANY SECRETARY. Dheeraj Gorukanti and Suguna Raman serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232TG2012PTC085058
- Company No.
085058
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Dec 2012
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Graviti Pharmaceuticals Private Limited
Explore comprehensive data for Graviti Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Graviti Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dheeraj Gorukanti  | Managing Director | 27-Dec-2012 | Current |
| Murali Vasudeva | Company Secretary | 06-Oct-2019 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suguna Raman | Director | 27-Dec-2012 | Current |
Financial Performance of Graviti Pharmaceuticals.
Graviti Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.02% increase. The company also saw a substantial fall in profitability, with a 110.34% decrease in profit. The company's net worth dipped by a decrease of 1.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Graviti Pharmaceuticals?
In 2023, Graviti Pharmaceuticals had a promoter holding of 49.00% and a public holding of 51.00%. The company had 3 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Daimen Pharma Private Limited
Dheeraj Gorukanti and Suguna Raman are mutual person
- Graviti Foundation
Dheeraj Gorukanti and Suguna Raman are mutual person
Yashoda Healthcare Services Private LimitedDheeraj Gorukanti is a mutual person
Fyzks Inspection Systems Private LimitedDheeraj Gorukanti and Suguna Raman are mutual person
- Daimen Capital Private Limited
Dheeraj Gorukanti is a mutual person
- Vigna Human Development Private Limited
Dheeraj Gorukanti and Suguna Raman are mutual person
Charges (Loans)
Open Charges
₹363.25 Cr
Satisfied Charges
₹160.00 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 245.25 Cr
- Others : 118.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Sep 2023 | Others | ₹118.00 Cr | Open |
| 22 Sep 2017 | Axis Bank Limited | ₹245.25 Cr | Open |
| 31 Mar 2015 | Axis Bank Limited | ₹160.00 Cr | Satisfied |
How Many Employees Work at Graviti Pharmaceuticals?
Graviti Pharmaceuticals has a workforce of 605 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Graviti Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Graviti Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Graviti Pharmaceuticals
Recent activity within the organization
- Charges
A charge with Others amounted to Rs. 118.00 Cr with Charge ID 100793871 was registered on 26 Sep 2023.
- Annual General Meeting
Graviti Pharmaceuticals Private Limited last Annual general meeting of members was held on 23 Sep 2023 as per latest MCA records.
- Balance Sheet
Graviti Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
- Charges
A charge with Axis Bank Limited of Rs. 245.25 Cr registered on 22 Sep 2017 with Charge ID 100132716 was modified on 01 Feb 2023.
- Director Appointment
Murali Sanyasi Rao Vasireddy Vasudeva was appointed as a Company Secretary was appointed as a Company Secretary on 06 Oct 2019 & has been associated with this company since 5 years 6 months .
- Charges
A charge with Axis Bank Limited amounted to Rs. 245.25 Cr with Charge ID 100132716 was registered on 22 Sep 2017.
Frequently asked questions
What is the Incorporation or founding date of Graviti Pharmaceuticals Private Limited?
Graviti Pharmaceuticals Private Limited was incorporated on 27 Dec 2012.
What is authorized share capital and paid-up capital of Graviti Pharmaceuticals Private Limited?
The authorized share capital of Graviti Pharmaceuticals Private Limited is ₹ 50.00 Cr and paid-up capital is ₹ 49.00 Cr.
Who are the current board members & directors of Graviti Pharmaceuticals Private Limited?
Currently 3 directors are associated with Graviti Pharmaceuticals Private Limited.
- Dheeraj Kumar Gorukanti
- Suguna Raman
- Murali Sanyasi Rao Vasireddy Vasudeva
What is the registered address of Graviti Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Graviti Pharmaceuticals Private Limited is House No. 8-2-248/1/7/64 Plot No.64 Nagarjuna Co-Operative Housing Society, Punjagutta India, Hyderabad, Telangana, 500082.
What is the corporate identification number (CIN) and company number of Graviti Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Graviti Pharmaceuticals Private Limited is U24232TG2012PTC085058 and the company number is 085058 as per Ministry of Corporate Affairs (MCA).
What is the official website of Graviti Pharmaceuticals Private Limited?
The Official website of Graviti Pharmaceuticals Private Limited is https://www.gravitipharma.com
What has been the recent revenue trend for Graviti Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Graviti Pharmaceuticals Private Limited has risen by 29.02%.
How many employees does Graviti Pharmaceuticals Private Limited currently have?
As Per 2023 financial reports, 605 employees are currently employed by Graviti Pharmaceuticals Private Limited.
What change has been observed in the net worth of Graviti Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Graviti Pharmaceuticals Private Limited has experienced an downturn of -1.01%.
What are the total open charges for Graviti Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Graviti Pharmaceuticals Private Limited amount to ₹ 363.25 Cr.
When was the last Balance Sheet of Graviti Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Graviti Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
RR
Ravender RaoDirector
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India